Brief: FDA Approves First Nasal Spray For Treatment Of Anaphylaxis

ARS Pharmaceuticals

09/08/2024 16:27

Aug 9 (Reuters) - FDA:
    * FDA APPROVES FIRST NASAL SPRAY FOR TREATMENT OF
ANAPHYLAXIS
    * FDA: APPROVED NEFFY (EPINEPHRINE NASAL SPRAY) FOR
EMERGENCY
TREATMENT OF ALLERGIC REACTIONS (TYPE I)

Further company coverage:  SPRY.O 

 ((Reuters.Briefs@thomsonreuters.com;))